Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

about

Activity of roniciclib in medullary thyroid cancer.

P2860

Q55363491-1ED95F1A-AAEE-48B6-B9DF-3A12F1D5CC7C

P2860

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

Item

http://www.wikidata.org/entity/Q42366591

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

@en

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

@nl

type

Item

label

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

@en

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

@nl

prefLabel

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

@en

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

@nl

P1476

Effects of roniciclib in preclinical models of anaplastic thyroid cancer

@en

P2093

Jen-Der Lin

http://www.w3.org/2001/XMLSchema#string

Richard J Wong

http://www.w3.org/2001/XMLSchema#string

Shu-Fu Lin

http://www.w3.org/2001/XMLSchema#string

Ting-Chao Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosome alignment and segregation regulated by ubiquitination of survivin

Cell cycle, CDKs and cancer: a changing paradigm

Management of anaplastic thyroid cancer

Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines

Aurora-A kinase is essential for bipolar spindle formation and early development

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma

Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy.

P304

67990-68000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19092

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chuen Hsueh

P577

2017-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978090

http://www.w3.org/2001/XMLSchema#string

P932

5620230

http://www.w3.org/2001/XMLSchema#string

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

about

P2860

P2860

Effects of roniciclib in preclinical models of anaplastic thyroid cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932